Τόμος 24 (2010) – Τεύχος 2 – Άρθρο 64 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 24 (2010) – Issue 2 – Article 64 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Laboratory of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Thessaly, Karditsa, Greece

pharmakonpress[at]pharmakonpress[.]gr

2. Bretveld R.W., Thomas C.M.G., Scheepers P.T.J., Zielhuis G.A., Roeleveld N.: Pesticide exposure: the hormonal function of the female reproductive system disrupted? Reprod. Biol. Endocrinol. 4: 30-58 (2006)

3. Simpson E.R., Zhao Y., Agarwal V.R., Michael M.D., Bulun S.E., Hinshelwood M.M., Graham-Lorence S., Sun T., Fisher C.R., Qin K., Mendelson M.D.: Aromatase expression in health and disease: Recent Prog. Horm. Res. 52: 185-213 (1997)

4. Diaz-Cruz E.S., Shpiro C.L., Brueggemeier R.W.: Cy-clooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells. J. Clin. Endocrinol. Metab. 90: 2563-2570 (2005)

5. Hiscox S., Davies E.L., Barrett-Lee P., Aromatase inhibitors in breast cancer. Maturitas. 63: 275-279 (2009)

6. Hardy D.B., Janowski B.A., Chen C-C., and Mendelson C.R.: Progesterone Receptor Inhibits Aromatase and Inflammatory Response Pathways in Breast Cancer Cells via Ligand-Dependent and Ligand-Independent Mechanisms. Mol. Endocrinol. 22: 1812–1824 (2008)

7. Srinivasan R., Karundevi B.: Corticosterone Induces Steroidogenic Lesion in Cultured Adult Rat Leydig Cells by Reducing the Expression of StAR Protein and Steroidogenic Enzymes. J. Cell. Biochem. 103: 1472-1487 (2008)

8. Watanabe M., Ohno S., Nakajin S.: Forskolin and dexamethasone synergistically induce aromatase (CYP19) expression in the human osteoblastic cell line SV-HFO. Eur. J. Endocrinol. 152: 619-624 (2005)

9. Yanase T., Mu Y-M., Nishi Y., Goto K., Nomura M., Okabe T., Takayanagi R., Nawata H.: Regulation of aromatase by nuclear receptors. J, Steroid Biochem. & Mol. Biol. 79: 187–192 (2008)

10. Watanabe M., Mariko Noda M., Nakajin S.: Effect of epidermal growth factor and prostaglandin on the expression of aromatase (CYP19) in human adrenocortical carcinoma cell line NCI-H295R cells. J. Endocrinol. 188: 59–68 (2006)

11. Kopelovich L., Fay J.R., Sigman C.C., Crowell J.A.: The Mammalian Target of Rapamycin Pathway as a Potential Target for Cancer Chemoprevention. Cancer Epidemiol. Biomarkers Prev. 16: 1330-40 (2007)

12. Davies G., L.-A. Martin L.-A., N. Sacks N., Dowsett M.: Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention. Ann. Oncol. 13: 669–678 (2002)

13. Kim J.I., Han E.H., Kim H.G., Oh K.N, Kim S.K., Lee K.Y., Jeong H.G.: Bisphenol A-induced aromatase activation is mediated by cyclooxygenase-2 upregulation in rat testicular Leydig cells. Toxicol. Lett. 193: 200–208 (2010)

14. Talbert D.R., Allred C.D., Zaytseva Y.Y., Kilgore M.W.: Transactivation of ERa by Rosiglitazone induces proliferation in breast cancer cells. Breast Cancer Res. Treat. 108: 23–33 (2008)

15. Yeb L., Chanb M.Y., Leung L.K.: The soy isoflavone genistein induces estrogen synthesis in an extragonadal pathway. Mol. Cell. Endocrinol. 302: 73-80 (2009)

16. Qiao Y., Jinyan Cao J., Liangqun Xie L., and Xiaolin Shi X.: Cell Growth Inhibition and Gene Expression Regulation by (-)-Epigallocatechin-3-Gallate in Human Cervical Cancer Cells. Arch. Pharm. Res. 32: 1309-1315 (2009)

17. Sun M., Estrov Z., Ji Y., Coombes K.R., Harris D.H., Kurzrock R.: Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol. Cancer Ther. 7:  464 (2008)

18. Rice S., Pellatt L., Ramanathan K., Whitehead S.A., Mason H.D.: Metformin inhibits aromatase via an ERK (extracellular signal-regulated kinase) – mediated pathway. Endocrinol. 150: 4794–4801 (2009)

19. Sanderson J.T., Hordijk J., Denison M.S., Springsteel M.F., Nantz M.H., van den Berg M.: Induction and Inhibition of Aromatase (CYP19) Activity by Natural and Synthetic Flavonoid Compounds in H295R Human Adrenocortical Carcinoma Cells. Toxicol. Sci. 82: 70–79 (2004)

20. Deb S., Zhou J., Amin S.A., Imir A.G., Yilmaz M.B., Lin Z., Bulun S.E.: A Novel Role of Sodium Butyrate in the Regulation of Cancer-associated Aromatase promoters I and II by Disrupting a Transcriptional Complex in Breast Adipose Fibroblasts. J. Biol. Chem. 281: 2585–2597 (2006)

21. Wong J.Y.Y, Huggins G.S., Debidda M., Munshi N.C., De Vivo I.: Dichloroacetate Induces Apoptosis in Endometrial Cancer Cells. Gynecol. Oncol. 109: 394–402 (2008)

22. Sanderson J.T., Boerma J., Lansbergen G.W.A., van den Berg M.: Induction and Inhibition of Aromatase (CYP19) Activity by Various Classes of Pesticides in H295R Human Adrenocortical Carcinoma Cells. Toxicol. Appl. Pharmacol. 182: 44–54, (2002)

23. Andersen H.R., Vinggaard A.M., Rasmussen T.H., Gjermandsen I.M., Bonefeld-Jørgensen E.C.: Effects of Currently Used Pesticides in Assays for Estrogenicity, Androgenicity, and Aromatase Activity in Vitro. Toxicol. Appl. Pharmacol. 179: 1–12 (2002)

24. Fan W., Yanase T., Morinaga H., Gondo S., Okabe T., Nomura M., Komatsu T., Morohashi K.I., Hayes T.B., Takayanagi R., Nawata H.: Atrazine-Induced Aromatase Expression Is SF-1 Dependent: Implications for Endocrine Disruption in Wildlife and Reproductive Cancers in Humans. Environ Health Perspect. 115: 720–727 (2007)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr